393 related articles for article (PubMed ID: 33889959)
1. The effect of polymorphisms in FSHR and FSHB genes on ovarian response: a prospective multicenter multinational study in Europe and Asia.
Polyzos NP; Neves AR; Drakopoulos P; Spits C; Alvaro Mercadal B; Garcia S; Ma PQM; Le LH; Ho MT; Mertens J; Stoop D; Tournaye H; Vuong NL
Hum Reprod; 2021 May; 36(6):1711-1721. PubMed ID: 33889959
[TBL] [Abstract][Full Text] [Related]
2. The effect of polymorphisms in FSHR gene on late follicular phase progesterone and estradiol serum levels in predicted normoresponders.
Neves AR; Vuong NL; Blockeel C; Garcia S; Alviggi C; Spits C; Ma PQM; Ho MT; Tournaye H; Polyzos NP
Hum Reprod; 2022 Oct; 37(11):2646-2654. PubMed ID: 36069495
[TBL] [Abstract][Full Text] [Related]
3. The BISTIM study: a randomized controlled trial comparing dual ovarian stimulation (duostim) with two conventional ovarian stimulations in poor ovarian responders undergoing IVF.
Massin N; Abdennebi I; Porcu-Buisson G; Chevalier N; Descat E; Piétin-Vialle C; Goro S; Brussieux M; Pinto M; Pasquier M; Bry-Gauillard H
Hum Reprod; 2023 May; 38(5):927-937. PubMed ID: 36864699
[TBL] [Abstract][Full Text] [Related]
4. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
[TBL] [Abstract][Full Text] [Related]
5. ESHRE guideline: ovarian stimulation for IVF/ICSI
Ovarian Stimulation TEGGO; Bosch E; Broer S; Griesinger G; Grynberg M; Humaidan P; Kolibianakis E; Kunicki M; La Marca A; Lainas G; Le Clef N; Massin N; Mastenbroek S; Polyzos N; Sunkara SK; Timeva T; Töyli M; Urbancsek J; Vermeulen N; Broekmans F
Hum Reprod Open; 2020; 2020(2):hoaa009. PubMed ID: 32395637
[TBL] [Abstract][Full Text] [Related]
6. FSHB -211 G>T is a major genetic modulator of reproductive physiology and health in childbearing age women.
Rull K; Grigorova M; Ehrenberg A; Vaas P; Sekavin A; Nõmmemees D; Adler M; Hanson E; Juhanson P; Laan M
Hum Reprod; 2018 May; 33(5):954-966. PubMed ID: 29617818
[TBL] [Abstract][Full Text] [Related]
7. Fertility preservation for women with breast cancer: a multicentre randomized controlled trial on various ovarian stimulation protocols.
Balkenende EME; Dahhan T; Beerendonk CCM; Fleischer K; Stoop D; Bos AME; Lambalk CB; Schats R; Smeenk JMJ; Louwé LA; Cantineau AEP; de Bruin JP; Linn SC; van der Veen F; van Wely M; Goddijn M
Hum Reprod; 2022 Jul; 37(8):1786-1794. PubMed ID: 35776109
[TBL] [Abstract][Full Text] [Related]
8. Cumulative delivery rate per aspiration IVF/ICSI cycle in POSEIDON patients: a real-world evidence study of 9073 patients.
Esteves SC; Yarali H; Vuong LN; Carvalho JF; Özbek İY; Polat M; Le HL; Pham TD; Ho TM; Humaidan P; Alviggi C
Hum Reprod; 2021 Jul; 36(8):2157-2169. PubMed ID: 34179973
[TBL] [Abstract][Full Text] [Related]
9. Does dual oocyte retrieval with continuous FSH administration increase the number of mature oocytes in low responders? An open-label randomized controlled trial.
Boudry L; Mateizel I; Wouters K; Papaleo E; Mackens S; De Vos M; Racca A; Adriaenssens T; Tournaye H; Blockeel C
Hum Reprod; 2024 Mar; 39(3):538-547. PubMed ID: 38199789
[TBL] [Abstract][Full Text] [Related]
10. Treatment with human, recombinant FSH improves sperm DNA fragmentation in idiopathic infertile men depending on the FSH receptor polymorphism p.N680S: a pharmacogenetic study.
Simoni M; Santi D; Negri L; Hoffmann I; Muratori M; Baldi E; Cambi M; Marcou M; Greither T; Baraldi E; Tagliavini S; Carra D; Lombardo F; Gandini L; Pallotti F; Krausz C; Rastrelli G; Ferlin A; Menegazzo M; Pignatti E; Linari F; Marino M; Benaglia R; Levi-Setti PE; Behre HM
Hum Reprod; 2016 Sep; 31(9):1960-9. PubMed ID: 27329968
[TBL] [Abstract][Full Text] [Related]
11. Androgen and inhibin B levels during ovarian stimulation before and after 8 weeks of low-dose hCG priming in women with low ovarian reserve.
Friis Wang N; Bogstad JW; Petersen MR; Pinborg A; Yding Andersen C; Løssl K
Hum Reprod; 2023 Sep; 38(9):1807-1815. PubMed ID: 37354554
[TBL] [Abstract][Full Text] [Related]
12. Ovarian response and embryo ploidy following oral micronized progesterone-primed ovarian stimulation versus GnRH antagonist protocol. A prospective study with repeated ovarian stimulation cycles.
Vidal MDM; Martínez F; Rodríguez I; Polyzos NP
Hum Reprod; 2024 May; 39(5):1098-1104. PubMed ID: 38498835
[TBL] [Abstract][Full Text] [Related]
13. Comparison of blastocyst euploidy rates following luteal versus follicular phase stimulation in a GnRH antagonist protocol: a prospective study with repeated ovarian stimulation cycles.
Martinez F; Clua E; Roca M; Garcia S; Polyzos NP
Hum Reprod; 2022 Nov; 37(12):2777-2786. PubMed ID: 36269092
[TBL] [Abstract][Full Text] [Related]
14. Cumulative live birth rates in low-prognosis women.
Leijdekkers JA; Eijkemans MJC; van Tilborg TC; Oudshoorn SC; van Golde RJT; Hoek A; Lambalk CB; de Bruin JP; Fleischer K; Mochtar MH; Kuchenbecker WKH; Laven JSE; Mol BWJ; Torrance HL; Broekmans FJM;
Hum Reprod; 2019 Jun; 34(6):1030-1041. PubMed ID: 31125412
[TBL] [Abstract][Full Text] [Related]
15. Eight weeks of androgen priming by daily low-dose hCG injections before ICSI treatment in women with low ovarian reserve.
Friis Wang N; Bogstad JW; Pors SE; Petersen MR; Pinborg A; Yding Andersen C; Løssl K
Hum Reprod; 2023 Apr; 38(4):716-725. PubMed ID: 36721920
[TBL] [Abstract][Full Text] [Related]
16. Serum progesterone is lower in ovarian stimulation with highly purified HMG compared to recombinant FSH owing to a different regulation of follicular steroidogenesis: a randomized controlled trial.
Bosch E; Alamá P; Romero JL; Marí M; Labarta E; Pellicer A
Hum Reprod; 2024 Feb; 39(2):393-402. PubMed ID: 38037188
[TBL] [Abstract][Full Text] [Related]
17. Impact of letrozole co-treatment during ovarian stimulation on oocyte yield, embryo development, and live birth rate in women with normal ovarian reserve: secondary outcomes from the RIOT trial.
Bülow NS; Warzecha AK; Nielsen MV; Andersen CY; Holt MD; Petersen MR; Sopa N; Zedeler A; Englund AL; Pinborg A; Grøndahl ML; Skouby SO; Macklon NS
Hum Reprod; 2023 Nov; 38(11):2154-2165. PubMed ID: 37699851
[TBL] [Abstract][Full Text] [Related]
18. Evidence-based guideline: unexplained infertility†.
; Romualdi D; Ata B; Bhattacharya S; Bosch E; Costello M; Gersak K; Homburg R; Mincheva M; Norman RJ; Piltonen T; Dos Santos-Ribeiro S; Scicluna D; Somers S; Sunkara SK; Verhoeve HR; Le Clef N
Hum Reprod; 2023 Oct; 38(10):1881-1890. PubMed ID: 37599566
[TBL] [Abstract][Full Text] [Related]
19. Ovarian response to controlled ovarian hyperstimulation: what does serum FSH say?
Oudshoorn SC; van Tilborg TC; Hamdine O; Torrance HL; Eijkemans MJC; Lentjes EGWM; Lambalk CB; Broekmans FJM
Hum Reprod; 2017 Aug; 32(8):1701-1709. PubMed ID: 28854580
[TBL] [Abstract][Full Text] [Related]
20. Fresh and cumulative live birth rates in mild versus conventional stimulation for IVF cycles in poor ovarian responders: a systematic review and meta-analysis.
Montoya-Botero P; Drakopoulos P; González-Foruria I; Polyzos NP
Hum Reprod Open; 2021; 2021(1):hoaa066. PubMed ID: 33614987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]